Columbia, Maryland, Nov. 18, 2011 (GLOBE NEWSWIRE) -- Columbia, MD - JPB Partners, LLC has announced that it provided strategic advisory services to Bioscan, Inc., of Washington, DC, in the sale of its radiopharmaceutical equipment operating division to Eckert & Ziegler of Berlin, Germany earlier this year. Terms of the transaction were not disclosed.
"When Bioscan made the decision to focus on its fast-growing molecular imaging business, we sought a partner that would enable us to find a strategic home for the radiopharmaceutical equipment business line and the thousands of customers that use Bioscan radioanalytic and radiochemistry instruments every day," stated Alex Kleinman, Vice President of Marketing and Business Development for Bioscan. "We are delighted that we selected JPB Partners to be that firm. JPB Partners brought industry knowledge from related transactions, coordinated the due diligence process, supported interactions and negotiations with Eckert & Ziegler, and managed the process in a first class, professional manner. With the help of JPB Partners, we not only received appropriate value for the business line, but also met our objections of finding a strategic home for our radiopharmaceutical equipment business with Ecker & Ziegler."
According to Mark Rohde, Senior Managing Director for JPB Partners’ Strategic Advisors, "The JPB Partners’ solution was based on quickly identifying the world-wide universe of potential strategic buyers and then working with Bioscan to find the most likely candidates to make a pre-emptive offer. Once a qualified set of strategic buyers was identified, JPB’s professional team identified and brought the most responsive bids to Bioscan." He added; "Working diligently against an investment deadline, JPB Partners closely managed the process from the initial offering to final selection and to closing. We were pleased to partner with Bioscan in meeting their goal of finding a strategic buyer, allowing them to devote new resources to core business sectors."
About Bioscan: Bioscan is a leading supplier of preclinical nano-tomographic molecular imaging systems that enable breakthroughs in the discovery, validation and development of novel therapeutics. For more information: www.bioscan.com
About Eckert & Ziegler: Eckert & Ziegler Strahlen- und Medizintechnik, AG is an isotope technology company which operates worldwide and is the holding company for a host of specialized subsidiaries engaged in the processing of radioisotopes as well as the development, production and the sales of isotope technical components, medical technical devices and related products. For more information: www.ezag.de
About JPB Partners: JPB Partners is a Columbia, Maryland-based services firm offering privately-held, lower-middle market companies creative solutions for long-term enterprise value creation in the areas of growth capital, strategic advisory services and real estate asset management. The family-owned company was founded in 1995 and has been enabling its clients to create a legacy of success for more than 15 years. For more information: www.jpbpartners.com